Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00939224 · ClinicalTrials.gov registry record

Study of Non-Invasive Regional Oxygen Saturations in Pediatric Patients Undergoing Cardiac Catheterization

A clinical trial of Cardiovascular Disease, sponsored by Nonin Medical.

Completed
Registry status
100
Enrollment target
3
Study locations

NCT00939224 is a study of Cardiovascular Disease that has completed, run by Nonin Medical. The registered enrollment target is 100 participants, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00939224, a study of Cardiovascular Disease, has completed, sponsored by Nonin Medical.

COMPLETED
Registry status
100 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to validate the Nonin Near-infrared spectroscopy (NIRS) device to measure regional oxygen saturation in a cohort of children with cardiovascular disease undergoing cardiac catheterization.

Conditions Studied

Interventions

  • DEVICE Model 7600 Regional Oximeter System

Study Locations (3)

California

  • Stanford University School of Medicine - Stanford

Illinois

  • Rush University Medical Center - Chicago

Ohio

  • Cincinnati Children Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2009-07
Est. Completion 2011-08

Sponsor

Nonin Medical

18 total trials

What the Registry Record Tells You About NCT00939224

The ClinicalTrials.gov registry entry for NCT00939224 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (96% lower). The listed sponsor is Nonin Medical, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Model 7600 Regional Oximeter System is the first listed.

NCT00939224 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Illinois, Ohio.

Frequently Asked Questions

What is clinical trial NCT00939224 about?

NCT00939224 is a clinical study titled "Study of Non-Invasive Regional Oxygen Saturations in Pediatric Patients Undergoing Cardiac Catheterization". The purpose of this study is to validate the Nonin Near-infrared spectroscopy (NIRS) device to measure regional oxygen saturation in a cohort of children with cardiovascular disease undergoing cardiac catheterization.

What is the current status of trial NCT00939224?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-07. Estimated completion is 2011-08.

What conditions does trial NCT00939224 study?

This clinical trial studies the following conditions: Cardiovascular Disease.

What interventions are being tested in trial NCT00939224?

The interventions under investigation include: Model 7600 Regional Oximeter System (DEVICE).

Who is sponsoring clinical trial NCT00939224?

This trial is sponsored by Nonin Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00939224 being conducted?

This trial has 3 study locations across California, Illinois, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.